Literature DB >> 18950457

Understanding haemophilic arthropathy: an exploration of current open issues.

Nathalie W D Jansen1, Goris Roosendaal, Floris P J G Lafeber.   

Abstract

Haemophilic arthropathy is joint damage evolving from recurrent joint bleeds that occur in patients suffering from the clotting disorder haemophilia. Insight into the pathogenetic mechanism of this blood-induced arthropathy yields possible treatment targets and modalities useful to reduce this invalidating co-morbidity of haemophilia. Joint bleeding leads to initially independent adverse changes in both the synovial tissue and the articular cartilage. These subsequently influence each other: the synovial inflammatory changes enhancing cartilage damage and vice versa. Consequently, effective treatment strategies will have to affect both pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950457     DOI: 10.1111/j.1365-2141.2008.07386.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  29 in total

1.  Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia.

Authors:  Paola Giordano; Giuseppe Lassandro; Riccardina Tesse; Stefania Longo; Federica Valente; Anna Rita Cappiello; Antonio Coppola
Journal:  Blood Transfus       Date:  2012-07-04       Impact factor: 3.443

Review 2.  Pathological mechanism of joint destruction in haemophilic arthropathy.

Authors:  Haijia Zhu; Yilin Meng; Peijian Tong; Shanxing Zhang
Journal:  Mol Biol Rep       Date:  2020-12-08       Impact factor: 2.316

3.  Assessment of Musculoskeletal Function and its Correlation with Radiological Joint Score in Children with Hemophilia A.

Authors:  Samriti Gupta; Kapil Garg; Jagdish Singh
Journal:  Indian J Pediatr       Date:  2015-05-08       Impact factor: 1.967

4.  Blood exposure has a negative effect on engineered cartilage.

Authors:  C Sosio; F Boschetti; L Mangiavini; C Scotti; S Manzotti; M S Buragas; S Biressi; G Fraschini; A Gigante; G M Peretti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-10-28       Impact factor: 4.342

5.  MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia.

Authors:  Wouter Foppen; Irene C van der Schaaf; Frederik J A Beek; Willem P T M Mali; Kathelijn Fischer
Journal:  Blood Adv       Date:  2020-01-14

6.  Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis.

Authors:  Junjiang Sun; Baolai Hua; Eric W Livingston; Sarah Taves; Peter B Johansen; Maureane Hoffman; Mirella Ezban; Dougald M Monroe; Ted A Bateman; Paul E Monahan
Journal:  Blood       Date:  2016-12-30       Impact factor: 22.113

7.  Prevalence of clinical hip abnormalities in haemophilia A and B: an analysis of the UDC database.

Authors:  D Kelly; Q C Zhang; J M Soucie; M Manco-Johnson; D Dimichele
Journal:  Haemophilia       Date:  2012-12-17       Impact factor: 4.287

8.  Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A.

Authors:  Daniela Melchiorre; Silvia Linari; Mirko Manetti; Eloisa Romano; Francesco Sofi; Marco Matucci-Cerinic; Christian Carulli; Massimo Innocenti; Lidia Ibba-Manneschi; Giancarlo Castaman
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941

9.  Recombinant factor VIII in the management of hemophilia A: current use and future promise.

Authors:  Jerry S Powell
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

10.  A long term results of external beam radiation therapy in hemophilic arthropathy of the ankle in children.

Authors:  Moonkyoo Kong; Jin Oh Kang; Jinhyun Choi; Seo Hyun Park
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.